Insights from new research could help expand treatment options beyond drugs Schizophrenia is a poorly understood illness, but scientists now have greater insight into one of the disorder’s hallmarks, auditory hallucinations, thanks to new research published Thursday. People with schizophrenia often “hear” voices and sounds even when there are none — up to 80% of...
Category: <span>Psychology & Psychiatry</span>
Post
Bright light therapy for non-seasonal depressive disorders
News Release 2-Oct-2024 JAMA Psychiatry Peer-Reviewed PublicationJAMA Network About The Study: The results of this systematic review and meta-analysis reveal that bright light therapy was an effective adjunctive treatment for non-seasonal depressive disorders. Additionally, results suggest that bright light therapy may improve the response time to the initial treatment. Corresponding Author: To contact the corresponding...
Post
DRUG MAY BOOST MOTIVATION FOR PEOPLE WITH DEPRESSION
SEPTEMBER 25TH, 2024POSTED BY EMORY UNIVERSITY(Credit: Getty Images) TAGS DEPRESSIONMOTIVATIONUNIVERSITY EMORY UNIVERSITYAn anti-inflammatory drug shows promise in boosting motivation for people with depression, a new study reveals. Motivational impairments are a core component of depression and have long been linked with poor treatment outcomes, diminished quality of life, and heightened suicide risk. Growing evidence suggests...
Post
Psychedelics excite cells in hippocampus to reduce anxiety, study finds
September 24, 2024 by Krishna Ramanujan, Cornell University A classic psychedelic, similar to LSD, psilocybin and mescalin, was found to activate a cell type in the brain that silences other neighboring neurons, a result that provides insight into how such drugs reduce anxiety, according to a new study. The findings show the psychedelic DOI (2,5-dimethoxy-4-iodoamphetamine)...
Post
Psychedelic drug psilocybin changes brain connectivity to treat body dysmorphic disorder
News Release 24-Sep-2024 Columbia University researchers uncover how a single dose of “magic mushrooms” changes brain connectivity to alleviate symptoms of the devastating mental illness Peer-Reviewed PublicationGenomic Press image: Whole brain multivariate pattern analysis (MVPA) reveals that seed brain regions including the thalamus 8 -6 8, insula -42 8 -6, inferior parietal lobe (IPL) -54...
Post
Conversion practice linked to greater risk of mental health symptoms, US surveys of LGBTQ+ people suggest
September 30, 2024 by Lancet People identifying as LGBTQ+ who have undergone conversion practice—commonly known as conversion therapy—are more likely to experience poor mental health, according to a study published in The Lancet Psychiatry journal. The findings—based on surveys of 4,426 LGBTQ+ adults in the U.S.—suggest people subjected to controversial practices targeting their gender identity...
Post
Autistic people and those with ADHD are more likely to have eating disorders
September 30, 2024 by Breanna Lepre and Lauren Ball, The Conversation More than 1.1 million Australians are estimated to be living with an eating disorder. Around one-third of these people are neurodivergent. So why are neurodivergent people, such as autistic people and those with ADHD, more likely to experience eating disorders than the broader population?...
Post
Wind phones help the bereaved deal with death, loss and grief—a clinical social worker explains
September 23, 2024 by Taryn Lindhorst, The Conversation The first wind phone was built in 2010 in Otsuchi, Japan. Credit: Matthew Komatsu/Wikimedia CommonsMy mother died in my home in hospice in 2020, on the day my state of Washington went into COVID-19 lockdown. Her body was taken away, but none of the usual touchstones for...
Post
Study suggests using neurostimulation therapies on a specific brain circuit could treat PTSD
September 24, 2024 by Brigham and Women’s Hospital Credit: Pixabay/CC0 Public DomainA study led by researchers at Brigham and Women’s Hospital evaluated 193 participants in the Vietnam Head Injury Study with penetrating traumatic brain injury. The team found those with damage connected to their amygdala, the fear center of the brain, were less likely to...
Post
Study shows psilocybin gives comparable long-term antidepressant effects to standard antidepressants
September 21, 2024 by European College of Neuropsychopharmacology Credit: CC0 Public DomainA direct comparison between the experimental psychedelic drug psilocybin and a standard SSRI antidepressant shows similar improvement of depressive symptoms, but that psilocybin offers additional longer-term benefits. The comparison, between psilocybin (the active ingredient in “magic mushrooms”) and the SSRI escitalopram gave similar long-term...